Thomas Struengmann News

FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 60,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!

About | View Sample | Privacy | Mobile Edition

Sponsorship Sales
Technology Vision Group - Santa Cruz , CA
Senior Regulatory Affairs Associate (Temporary Position)
Core Logic, Inc. - California / Central, CA
Vice President of Sales and Marketing
Harvard Group International - Mid Atlantic-Philadelphia, PA
Medical Director
Pharmacruiting, LLC - Hudson Co., NJ
Research Associate II/III - Recombinant Protein
eBioscience - San Diego, CA

More Jobs >>

Personalized Medicine – From concept to reality
How will a new era of personalized medicine revolutionize the drug development process? Fi
How Business Intelligence Can Dramatically Improve Your Business Operations
Quest Diagnostics is one of the largest providers of global central laboratory services pe
Clinical Trial Design — The R&D Dilemma
From competition for volunteers to the emphasis on safety forcing developers to rethink ho

More Webinars >>

Most Popular Thomas Struengmann Story

Struengmanns to invest in German biotech firms

August 21, 2008 — 10:57am ET | By John Carroll

Twin brothers Thomas and Andreas Struengmann made a fortune selling their generic drug business back in 2005. Now they plan to invest a good bit of their money in Germany's biotech industry. In an... Read more...

Free Newsletter

Most Popular Stories

Featured Jobs

Webinars

Events

Most Popular Thomas Struengmann Story

Struengmanns to invest in German biotech firms

Latest Headlines

Paid Research Reports

THE FIERCEMARKETS NETWORK